Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leonardo Lucantoni

Showing results (31-40 of 43) with videos related to

Pageof 5
Sort By:
Acta Tropica|June 7, 2012
Efficacy of sunlight-activatable porphyrin formulates on larvae of Anopheles gambiae M and S molecular forms and An. arabiensis: a potential novel biolarvicide for integrated malaria vector controlClara Fabris, Robert Kossivi Ouédraogo, Olimpia Coppellotti, et al.
Nature Communications|February 1, 2017
SC83288 is a clinical development candidate for the treatment of severe malariaStefano Pegoraro, Maëlle Duffey, Thomas D Otto, et al.
Molecules (Basel, Switzerland)|December 2, 2017
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage AntimalarialNicoletta Basilico, Silvia Parapini, Anna Sparatore, et al.
Parasites & Vectors|April 17, 2014
Transmission blocking activity of Azadirachta indica and Guiera senegalensis extracts on the sporogonic development of Plasmodium falciparum field isolates in Anopheles coluzzii mosquitoesRakiswendé S Yerbanga, Leonardo Lucantoni, Robert K Ouédraogo, et al.
The Journal of Clinical Investigation|February 12, 2020
A Plasmodium vivax experimental human infection model for evaluating efficacy of interventionsKatharine A Collins, Claire Yt Wang, Matthew Adams, et al.
Malaria Journal|July 26, 2015
Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compoundsSolomon M Abay, Leonardo Lucantoni, Nisha Dahiya, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria ParasiteKatherine M Ellis, Leonardo Lucantoni, Marina Chavchich, et al.
Journal of Medicinal Chemistry|August 26, 2021
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious AntimalarialsBenoît Laleu, Yuichiro Akao, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|November 14, 2012
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agentsSandra Gemma, Caterina Camodeca, Margherita Brindisi, et al.
Nature Microbiology|August 16, 2017
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activityManu Vanaerschot, Leonardo Lucantoni, Tao Li, et al.
Pageof 5

Showing results (31-40 of 43) with videos related to

Sort By:
Pageof 5
Acta Tropica|June 7, 2012
Efficacy of sunlight-activatable porphyrin formulates on larvae of Anopheles gambiae M and S molecular forms and An. arabiensis: a potential novel biolarvicide for integrated malaria vector controlClara Fabris, Robert Kossivi Ouédraogo, Olimpia Coppellotti, et al.
Nature Communications|February 1, 2017
SC83288 is a clinical development candidate for the treatment of severe malariaStefano Pegoraro, Maëlle Duffey, Thomas D Otto, et al.
Molecules (Basel, Switzerland)|December 2, 2017
In Vivo and In Vitro Activities and ADME-Tox Profile of a Quinolizidine-Modified 4-Aminoquinoline: A Potent Anti-P. falciparum and Anti-P. vivax Blood-Stage AntimalarialNicoletta Basilico, Silvia Parapini, Anna Sparatore, et al.
Parasites & Vectors|April 17, 2014
Transmission blocking activity of Azadirachta indica and Guiera senegalensis extracts on the sporogonic development of Plasmodium falciparum field isolates in Anopheles coluzzii mosquitoesRakiswendé S Yerbanga, Leonardo Lucantoni, Robert K Ouédraogo, et al.
The Journal of Clinical Investigation|February 12, 2020
A Plasmodium vivax experimental human infection model for evaluating efficacy of interventionsKatharine A Collins, Claire Yt Wang, Matthew Adams, et al.
Malaria Journal|July 26, 2015
Plasmodium transmission blocking activities of Vernonia amygdalina extracts and isolated compoundsSolomon M Abay, Leonardo Lucantoni, Nisha Dahiya, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
The Novel bis-1,2,4-Triazine MIPS-0004373 Demonstrates Rapid and Potent Activity against All Blood Stages of the Malaria ParasiteKatherine M Ellis, Leonardo Lucantoni, Marina Chavchich, et al.
Journal of Medicinal Chemistry|August 26, 2021
Discovery and Structure-Activity Relationships of Quinazolinone-2-carboxamide Derivatives as Novel Orally Efficacious AntimalarialsBenoît Laleu, Yuichiro Akao, Atsuko Ochida, et al.
Journal of Medicinal Chemistry|November 14, 2012
Mimicking the intramolecular hydrogen bond: synthesis, biological evaluation, and molecular modeling of benzoxazines and quinazolines as potential antimalarial agentsSandra Gemma, Caterina Camodeca, Margherita Brindisi, et al.
Nature Microbiology|August 16, 2017
Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activityManu Vanaerschot, Leonardo Lucantoni, Tao Li, et al.
Pageof 5